INNATE PHARMA SAS has a total of 13 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SUPPREMOL GMBH, TOPOTARGET SWITZERLAND SA and TEDDER THOMAS F.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Argentina | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Organic fine chemistry | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Sugars | |
#6 | Microorganisms | |
#7 | Analysing materials | |
#8 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Moretta Alessandro | 9 |
#2 | Biassoni Roberto | 8 |
#3 | Bottino Cristina | 5 |
#4 | Bottino Chistina | 3 |
#5 | Romagne Francois | 2 |
#6 | Pascale Andre | 2 |
#7 | Laurent Gauthier | 1 |
#8 | Wagtmann Peter Andreas Nicolai Reumert | 1 |
#9 | Tiollier Jerome | 1 |
#10 | Soren Berg Padkjaer | 1 |
Publication | Filing date | Title |
---|---|---|
US2002142445A1 | Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same | |
CA2288307A1 | Novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same |